Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Human vaccines & immunotherapeutics: News October 2022156
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China107
Vaccine manufacturing is essential to ensure access103
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’102
Human vaccines and immunotherapeutics: News December 202395
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia87
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She84
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling73
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria73
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study73
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies66
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study63
Healthcare workers’ and caregivers’ knowledge, perceptions and experiences of the school-based human papillomavirus (HPV) immunization program: A qualitative study in eThekwini District of the KwaZulu63
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)62
Determinants of basic childhood vaccination coverage in European and OECD countries59
Enhancing COVID-19 booster vaccination among the elderly through text message reminders58
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary58
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam56
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control56
Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence55
Acute encephalitis after COVID-19 vaccination: A case report and literature review54
Correction54
Drivers and barriers to influenza vaccination in the post–COVID-19 era in the Federation of Bosnia and Herzegovina: A qualitative study using focus groups with risk groups and in-depth interviews with51
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector50
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 202148
Bacteriophages as vaccine platforms: Opportunities and challenges in translation47
PV-10 enhances immune responses in hepatitis B vaccination through STING pathway46
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children45
HV&I Reviewer Highlight41
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak40
Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents40
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities40
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children39
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality39
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons39
How to make effective HPV vaccine recommendations starting at age 938
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain38
0.25219511985779